When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MRK - Agile Therapeutics: Billion Dollar Buy-Out Is On The Horizon
Merck & Company Inc.
Introduction
Agile Therapeutics (NASDAQ: AGRX) is a women’s healthcare company focused on patch-based contraceptive options. Their lead product, Twirla, is a once-a-week contraceptive patch containing a combined dose of levonorgestrel and ethinyl estradiol. Twirla was recently approved by the FDA on February 14, 2020 for women with a BMI < 30 kg/m2 and is contraindicated in women with a BMI > 30 kg/m2.
Twirla endured a long and difficult path to approval, including several CRLs and a scathing set of briefing documents issued by the FDA prior to their AdComm in